Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Mersana Therapeutics Inc (NASDAQ: MRSN) closed at $0.48 in the last session, down -3.67% from day before closing price of $0.50. In other words, the price has decreased by -$3.67 from its previous closing price. On the day, 2.67 million shares were traded.
Ratios:
We take a closer look at MRSN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.19 and its Current Ratio is at 2.19.
JP Morgan Upgraded its Underweight to Neutral on March 19, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 16 ’25 when Mandelia Ashish sold 3,554 shares for $0.58 per share. The transaction valued at 2,061 led to the insider holds 57,519 shares of the business.
Protopapas Anna sold 8,637 shares of MRSN for $5,009 on Jan 16 ’25. The Director now owns 168,041 shares after completing the transaction at $0.58 per share. On Jan 16 ’25, another insider, Lowinger Timothy B, who serves as the SVP, Chief Sci.&Tech. Officer of the company, sold 8,048 shares for $0.58 each. As a result, the insider received 4,668 and left with 257,673 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.49.
Stock Price History:
Over the past 52 weeks, MRSN has reached a high of $6.28, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -34.23%, while the 200-Day Moving Average is calculated to be -71.09%.
Shares Statistics:
A total of 115.65M shares are outstanding, with a floating share count of 85.81M. Insiders hold about 31.15% of the company’s shares, while institutions hold 54.62% stake in the company.
